NUZYRA CENTRAL
LIVE

Serial Number

88133071

Owner

Paratek Pharmaceuticals, Inc.

Attorney

KEITH TOMS

First Use Date

Feb 14, 2019

Filing Date

Sep 26, 2018

Add to watchlist:

No watchlists yet
View on USPTO

NUZYRA CENTRAL Trademark

Serial Number: 88133071 • Registration: 7064589

NUZYRA CENTRAL is a trademark filed by Paratek Pharmaceuticals, Inc. on September 26, 2018. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Paratek Pharmaceuticals, Inc. (53 trademarks)

75 Kneeland Street
Boston, MA 02111

Entity Type: 03

Trademark Details

Filing Date

September 26, 2018

Registration Date

May 30, 2023

First Use Anywhere

February 14, 2019

First Use in Commerce

February 14, 2019

Published for Opposition

January 22, 2019

Goods & Services

Insurance consultancy services in the field of health; Insurance services, namely, insurance eligibility review and verification and consultation in the pharmaceutical industry; Pharmaceutical benefit management services; Insurance administration services, namely, assisting others with applying for insurance benefits

Providing information in the fields of health, medicine, and pharmaceuticals for the treatment of infectious disease; Medical information services, namely, providing information to physicians, healthcare professionals, and patients on the topics of health issues, pharmaceutical products, and health awareness in the field of infectious diseases; Health care services, namely, providing patient access programs to provide eligible patients with streamlined access to drugs; Dispensing of pharmaceuticals; Providing an internet website for medical professionals and medical patients featuring medical information that enables users to enter, access, track, monitor and generate health and medical information

Printed medication dosage and formulation charts; printed informational cards and brochures in the field of infectious disease; printed informational cards and brochures in the field of pharmaceutical preparations, namely, antibiotics

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 20, 2026 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 20, 2026 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 28, 2025 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 30, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 30, 2023 R.PR
REVIEW OF CORRESPONDENCE COMPLETE
May 11, 2023 CORV
ASSIGNED TO PETITION STAFF
May 11, 2023 APET
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 28, 2023 ERRR
ATTORNEY REVIEW COMPLETED
Apr 27, 2023 ATRV
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2023 CRFA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 20, 2023 EPPA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2023 CRFA
EXPARTE APPEAL TERMINATED
Jan 26, 2023 EXPT
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Jan 26, 2023 PBSR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 26, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 25, 2023 CNPR
EX PARTE APPEAL-INSTITUTED
Jan 23, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 23, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 23, 2023 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 19, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 21, 2022 GNFN
FINAL REFUSAL E-MAILED
Jul 21, 2022 GNFR
SU - FINAL REFUSAL - WRITTEN
Jul 21, 2022 CNFR
ASSIGNED TO EXAMINER
Jun 15, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 3, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 3, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 3, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2021 TROA
SOU TEAS EXTENSION RECEIVED
Sep 14, 2021 EEXT
ASSIGNED TO EXAMINER
Aug 30, 2021 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 3, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 3, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 3, 2021 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 7, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Apr 6, 2021 SUPC
SOU EXTENSION 4 GRANTED
Apr 6, 2021 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 6, 2021 AITU
USE AMENDMENT FILED
Mar 22, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 22, 2021 EISU
SOU EXTENSION 4 FILED
Mar 18, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 18, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2020 EXRA
SOU EXTENSION 3 GRANTED
Sep 17, 2020 EX3G
SOU EXTENSION 3 FILED
Sep 17, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 17, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2020 EXRA
SOU EXTENSION 2 GRANTED
Mar 12, 2020 EX2G
SOU EXTENSION 2 FILED
Mar 12, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 12, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2019 EXRA
SOU EXTENSION 1 GRANTED
Sep 9, 2019 EX1G
SOU EXTENSION 1 FILED
Sep 9, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 9, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 19, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 22, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 2, 2019 NONP
ASSIGNED TO LIE
Dec 9, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 20, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 20, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 20, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 20, 2018 CNEA
ASSIGNED TO EXAMINER
Nov 15, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2018 NWOS
NEW APPLICATION ENTERED
Sep 29, 2018 NWAP